{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:28:43Z","timestamp":1790980123848,"version":"4.1.0"},"reference-count":35,"publisher":"American Association for Cancer Research (AACR)","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18km0605001"],"award-info":[{"award-number":["JP18km0605001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19kk0305010"],"award-info":[{"award-number":["JP19kk0305010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ama121015"],"award-info":[{"award-number":["JP22ama121015"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ck0106805"],"award-info":[{"award-number":["JP23ck0106805"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19kk0305010"],"award-info":[{"award-number":["JP19kk0305010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23tm0624002"],"award-info":[{"award-number":["JP23tm0624002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Ministry of Education, Science, Sports, Culture, and Technology of Japan","award":["23K19459"],"award-info":[{"award-number":["23K19459"]}]},{"name":"The Ministry of Education, Science, Sports, Culture, and Technology of Japan","award":["24K20206"],"award-info":[{"award-number":["24K20206"]}]},{"name":"Special Postdoctoral Researcher Program at RIKEN"},{"name":"The Yasuda Medical Foundation"},{"DOI":"10.13039\/100007449","name":"The Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The MSD Life Science Foundation"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Clonal hematopoiesis of indeterminate potential (CHIP) has broad clinical relevance, and TP53 plays various roles within cells. However, the gene-specific and cross-disease significance of CHIP with TP53 mutations (TP53-CHIP) remains unclear. In this study, we evaluated TP53-CHIP using targeted sequencing data of 140,597 individuals without hematologic neoplasms in BioBank Japan. We identified 1,157 individuals with TP53-CHIP and clarified the characteristics of mutations and carriers. TP53-CHIP was associated with poor overall survival, especially because of lymphoid neoplasms and respiratory disease, in addition to myeloid neoplasms. Significant interactions accompanied by excess risks were observed between TP53-CHIP and lifestyle factors for disease-specific mortality: acetaldehyde exposure (resulting from the interaction between drinking and the germline variant of ALDH2) for myeloid neoplasms and smoking for respiratory disease. The clinical significance of TP53-CHIP was sometimes largely independent of variant allele fractions. These findings elucidate aspects of disease pathogenesis and inform personalized risk management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>TP53-CHIP contributed to a wide range of outcomes besides myeloid neoplasm mortality. TP53-CHIP, when combined with environmental factors, showed a remarkably higher risk for disease-specific mortality, accompanied by excess risks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-24-0355","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T08:31:54Z","timestamp":1750149114000},"page":"298-306","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical Significance of\n                    <i>TP53<\/i>\n                    -Mutant Clonal Hematopoiesis Across Diseases"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6180-0704","authenticated-orcid":false,"given":"Yoshiaki","family":"Usui","sequence":"first","affiliation":[{"name":"1Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4246-6497","authenticated-orcid":false,"given":"Mikiko","family":"Endo","sequence":"additional","affiliation":[{"name":"1Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8576-1775","authenticated-orcid":false,"given":"Yusuke","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"1Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7640-0882","authenticated-orcid":false,"given":"Hanae","family":"Iijima","sequence":"additional","affiliation":[{"name":"1Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1807-772X","authenticated-orcid":false,"given":"Hidewaki","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"2Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7292-2686","authenticated-orcid":false,"given":"Koichi","family":"Matsuda","sequence":"additional","affiliation":[{"name":"3Laboratory of Clinical Genome Sequencing, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-3504","authenticated-orcid":false,"given":"Yukihide","family":"Momozawa","sequence":"additional","affiliation":[{"name":"1Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"2025070103071110600_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1152\/physrev.00004.2022","article-title":"Clonal hematopoiesis, somatic mosaicism, and age-associated disease","volume":"103","author":"Evans","year":"2023","journal-title":"Physiol Rev"},{"key":"2025070103071110600_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.18.00331","article-title":"Managing clonal hematopoiesis in patients with solid tumors","volume":"37","author":"Bolton","year":"2019","journal-title":"J Clin Oncol"},{"key":"2025070103071110600_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41576-024-00709-x","article-title":"Genetic variation across and within individuals","volume":"25","author":"Yu","year":"2024","journal-title":"Nat Rev Genet"},{"key":"2025070103071110600_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"Cancer. p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"key":"2025070103071110600_bib5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","article-title":"Somatic mutations precede acute myeloid leukemia years before diagnosis","volume":"24","author":"Desai","year":"2018","journal-title":"Nat Med"},{"key":"2025070103071110600_bib6","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2022.05.006","article-title":"Clonal hematopoiesis: mutation-specific adaptation to environmental change","volume":"29","author":"Florez","year":"2022","journal-title":"Cell Stem Cell"},{"key":"2025070103071110600_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","article-title":"Common and rare variant associations with clonal haematopoiesis phenotypes","volume":"612","author":"Kessler","year":"2022","journal-title":"Nature"},{"key":"2025070103071110600_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","article-title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","volume":"586","author":"Bick","year":"2020","journal-title":"Nature"},{"key":"2025070103071110600_bib9","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.je.2016.12.005","article-title":"Overview of the BioBank Japan project: study design and profile","volume":"27","author":"Nagai","year":"2017","journal-title":"J Epidemiol"},{"key":"2025070103071110600_bib10","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.je.2016.12.003","article-title":"Cross-sectional analysis of BioBank Japan clinical data: a large cohort of 200,000 patients with 47 common diseases","volume":"27","author":"Hirata","year":"2017","journal-title":"J Epidemiol"},{"key":"2025070103071110600_bib11","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.je.2016.12.006","article-title":"Overview of BioBank Japan follow-up data in 32 diseases","volume":"27","author":"Hirata","year":"2017","journal-title":"J Epidemiol"},{"key":"2025070103071110600_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00017.2013","article-title":"Targeting aldehyde dehydrogenase 2: new therapeutic opportunities","volume":"94","author":"Chen","year":"2014","journal-title":"Physiol Rev"},{"key":"2025070103071110600_bib13","first-page":"5027","article-title":"Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population","volume":"25","author":"Momozawa","year":"2016","journal-title":"Hum Mol Genet"},{"key":"2025070103071110600_bib14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/2643-3230.BCD-22-0154","article-title":"Adult low-hypodiploid acute lymphoblastic leukemia emerges from preleukemic TP53-mutant clonal hematopoiesis","volume":"4","author":"Kim","year":"2023","journal-title":"Blood Cancer Discov"},{"key":"2025070103071110600_bib15","doi-asserted-by":"crossref","first-page":"e1003444","DOI":"10.1371\/journal.pgen.1003444","article-title":"Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases","volume":"9","author":"Ferreira","year":"2013","journal-title":"PLoS Genet"},{"key":"2025070103071110600_bib16","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41588-021-00928-6","article-title":"Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence","volume":"53","author":"Moody","year":"2021","journal-title":"Nat Genet"},{"key":"2025070103071110600_bib17","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1158\/2159-8290.CD-23-0902","article-title":"Pan-cancer comparative and integrative analyses of driver alterations using Japanese and International Genomic Databases","volume":"14","author":"Horie","year":"2024","journal-title":"Cancer Discov"},{"key":"2025070103071110600_bib18","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.molcel.2023.05.035","article-title":"Genotoxic aldehyde stress prematurely ages hematopoietic stem cells in a p53-driven manner","volume":"83","author":"Wang","year":"2023","journal-title":"Mol Cell"},{"key":"2025070103071110600_bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/blood.2021013531","article-title":"Association of clonal hematopoiesis with chronic obstructive pulmonary disease","volume":"139","author":"Miller","year":"2022","journal-title":"Blood"},{"key":"2025070103071110600_bib20","doi-asserted-by":"crossref","first-page":"665897","DOI":"10.3389\/fcell.2021.665897","article-title":"Role of Tet2 in regulating adaptive and innate immunity","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025070103071110600_bib21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/s41388-018-0524-5","article-title":"p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance","volume":"38","author":"Zhang","year":"2019","journal-title":"Oncogene"},{"key":"2025070103071110600_bib22","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1038\/s41467-018-06581-8","article-title":"Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls","volume":"9","author":"Momozawa","year":"2018","journal-title":"Nat Commun"},{"key":"2025070103071110600_bib23","doi-asserted-by":"crossref","first-page":"103033","DOI":"10.1016\/j.ebiom.2020.103033","article-title":"Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes","volume":"60","author":"Mizukami","year":"2020","journal-title":"EBioMedicine"},{"key":"2025070103071110600_bib24","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.cgh.2020.12.007","article-title":"Population-based screening for hereditary colorectal cancer variants in Japan","volume":"20","author":"Fujita","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025070103071110600_bib25","first-page":"1962","article-title":"Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls","volume":"31","author":"Sekine","year":"2022","journal-title":"Hum Mol Genet"},{"key":"2025070103071110600_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2022.09.025","article-title":"Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer","volume":"78","author":"Okawa","year":"2023","journal-title":"J Hepatol"},{"key":"2025070103071110600_bib27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa2211807","article-title":"Helicobacter pylori, homologous-recombination genes, and gastric cancer","volume":"388","author":"Usui","year":"2023","journal-title":"N Engl J Med"},{"key":"2025070103071110600_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/humu.23910","article-title":"A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically","volume":"41","author":"Coffee","year":"2020","journal-title":"Hum Mutat"},{"key":"2025070103071110600_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"2025070103071110600_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat Methods Med Res"},{"key":"2025070103071110600_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"2025070103071110600_bib32","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41591-021-01411-9","article-title":"Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis","volume":"27","author":"Saiki","year":"2021","journal-title":"Nat Med"},{"key":"2025070103071110600_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"},{"key":"2025070103071110600_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/em-2013-0005","article-title":"A tutorial on interaction","volume":"3","author":"VanderWeele","year":"2014","journal-title":"Epidemiologic Methods"},{"key":"2025070103071110600_bib35","article-title":"Med4way: a Stata command to investigate mediating and interactive mechanisms using the four-way effect decomposition","author":"Discacciati","year":"2018  16","journal-title":"Int J Epidemiol"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-24-0355\/3621646\/bcd-24-0355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/6\/4\/298\/3625985\/bcd-24-0355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/6\/4\/298\/3625985\/bcd-24-0355.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T03:07:22Z","timestamp":1751339242000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/6\/4\/298\/763151\/Clinical-Significance-of-TP53-Mutant-Clonal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,6,17]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-24-0355","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.29444740","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444752","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444731","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444698","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444695","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444692","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444707","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444719","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444743","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444710","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444722","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444734","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444701","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444746","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444713","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444725","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444737","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444704","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444716","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444749","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.29444728","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.7903450","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}